<?xml version="1.0" encoding="UTF-8"?>
<p id="Par34">The interplay of complex host and viral genetic differences is likely to play a huge role in determining pathologic outcomes in PWH. For example, differences in HIV strains/variants (Rao et al. 
 <xref ref-type="bibr" rid="CR420">2013</xref>) and human/host genetic variability (Proudnikov et al. 
 <xref ref-type="bibr" rid="CR406">2012</xref>), pharmacokinetics (Kuhlman et al. 
 <xref ref-type="bibr" rid="CR263">1996</xref>; Eap et al. 
 <xref ref-type="bibr" rid="CR127">2002</xref>; Elkader and Sproule 
 <xref ref-type="bibr" rid="CR139">2005</xref>; Kharasch 
 <xref ref-type="bibr" rid="CR232">2017</xref>; Kringen et al. 
 <xref ref-type="bibr" rid="CR261">2017</xref>), and sex (Zubieta et al. 
 <xref ref-type="bibr" rid="CR563">2002</xref>; Taylor and Davies 
 <xref ref-type="bibr" rid="CR501">2010</xref>; Venuto et al. 
 <xref ref-type="bibr" rid="CR525">2014</xref>; Marinho et al. 
 <xref ref-type="bibr" rid="CR308">2019</xref>) all contribute to variability in responsiveness. The following subsections will focus on key factors affecting opioid and HIV comorbidity.
</p>
